List of works - Santiago Montes-Moreno

A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma

scientific article

A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group

scientific article published on 06 May 2018

A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages

scientific article

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

scientific article published on 13 June 2017

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

scientific article

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

scientific article

Anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report with particular immunophenotypic features

scientific article published on 24 January 2013

Angioimmunoblastic T-cell lymphoma with a clonal plasma cell proliferation that underwent immunoglobulin isotype switch in the skin, coinciding with cutaneous disease progression

scientific article published on 04 October 2016

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

scientific article published on February 2014

BCL7A protein expression in normal and malignant lymphoid tissues.

scientific article published on 9 October 2012

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

scientific article published on 12 December 2018

CD 30-positive transformed follicular lymphoma: two case reports and literature review.

scientific article published on 06 May 2015

CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options

scientific article

CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.

scientific article published on 16 November 2015

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

scientific article published on 23 January 2013

Castleman Disease and Rosai-Dorfman Disease.

scientific article published on 2 December 2017

Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: A previously undescribed association of findings

scientific article published on 11 August 2005

Childhood florid follicular hyperplasia with immunoglobulin light-chain restriction in the gastrointestinal tract

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

scientific article published on 31 December 2014

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

scientific article published on 29 February 2016

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.

scientific article published on 21 June 2011

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

scientific article

Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era

scientific article published in PLoS ONE

Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

scientific article published on 07 April 2018

Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway

scientific article

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

scientific article published on 22 March 2012

Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.

scientific article

DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers

scientific article published on 25 October 2018

Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS

scientific article published on 24 January 2020

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

scientific article

E2F4 plays a key role in Burkitt lymphoma tumorigenesis

scientific article

EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults

scientific article published on December 2010

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation

scientific article published on 27 April 2012

Early phase of Epstein-Barr virus (EBV)-positive diffuse large B cell lymphoma of the elderly mimicking EBV-positive reactive follicular hyperplasia

scientific article published in September 2011

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

scientific article published on 26 July 2011

Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options

scientific article published on 3 February 2016

Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases

scientific article published on December 2011

Erdheim-Chester disease with isolated skeletal involvement in patient with odontalgia.

scientific article

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.

scientific article published on 24 August 2012

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

scientific article

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

scientific article published on 27 September 2013

Expression pattern of XBP1(S) in human B-cell lymphomas

scientific article published on 27 January 2009

Follicular T-cell lymphoma: description of a case with characteristic findings suggesting it is a different condition from AITL

scientific article published on 01 June 2009

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

scientific article

Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma

scientific article published on 09 April 2020

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

scientific article published on 31 August 2010

Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

scientific article published on 26 September 2017

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.

scientific article published on 9 August 2013

Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice

scientific article published on 13 June 2012

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

scientific article published on 14 November 2015

Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment ⬇️

scientific article published on October 24, 2010

Identification of MNDA as a new marker for nodal marginal zone lymphoma.

scientific article

Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues

article published in 2011

In situ neoplasia in lymph node pathology.

scientific article published on 9 November 2017

Incidental and Isolated Follicular Lymphoma In Situ and Mantle Cell Lymphoma In Situ Lack Clinical Significance

scientific article published on 3 March 2016

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

article

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

scientific article published on 21 March 2011

Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.

scientific article

Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases.

scientific article published in April 2010

Lack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma

scientific article

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge

scientific article published on 19 September 2011

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.

scientific article published on 5 February 2016

Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.

scientific article published on 18 December 2014

Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.

scientific article published on 22 May 2009

Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis

scientific article published on 20 December 2019

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

scientific article published on 27 August 2013

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

scientific article published on 28 February 2013

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.

scientific article published on May 2015

MYD88L265P mutated IgA lymphoplasmacytic lymphoma

scientific article published on 02 August 2019

MicroRNA signatures in B-cell lymphomas.

scientific article published on 17 February 2012

MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

scientific article published on 31 August 2012

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

scientific article

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

scientific article

NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas.

scientific article

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

scientific article published on 07 March 2014

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

scientific article published on 27 March 2013

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

scientific article published on 22 November 2011

Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins

PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma

scientific article

Pathology reporting of bone marrow biopsy in myelofibrosis; application of the Delphi consensus process to the development of a standardised diagnostic report

article

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

scientific article published on 28 August 2012

Peripheral T-cell lymphoma with follicular T-cell markers

scientific article published on December 2008

Persistent polyclonal B-cell lymphocytosis with splenomegaly: histologic description of 2 cases

scientific article published in July 2013

Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.

scientific article

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

scientific article published on 19 March 2014

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

scientific article

Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.

scientific article

Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features

Primary luetic lymphadenopathy simulating sarcoma-like inflammatory pseudotumour of the lymph node

Procesos linfoproliferativos múltiples en un paciente

scientific article published on 29 January 2016

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

scientific article published on 7 August 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

scientific article

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

scientific article published on 12 November 2015

Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place

scientific article published on 14 January 2010

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

scientific article published on 08 December 2016

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia

scientific article published on 21 February 2018

Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis.

scientific article published on 24 April 2014

SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms

scientific article published on 19 November 2012

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

scientific article published on 20 March 2013

Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma

article

Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features

scientific article

Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases

scientific article published in May 2009

Spontaneously Ruptured Spleen Samples in Patients With Infectious Mononucleosis: Analysis of Histology and Lymphoid Subpopulations

scientific article published on 01 August 2018

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.

scientific article published on 19 February 2016

TCL1A expression delineates biological and clinical variability in B-cell lymphoma

scientific article published on 26 September 2008

TCR-γ expression in primary cutaneous T-cell lymphomas.

scientific article

Targeting CD30 expression in diverse Large B-cell lymphoma entities

The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma

scientific article

The broad and challenging landscape of extranodal lymphoproliferations

scientific article published on 22 November 2019

The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome

scientific article published on 28 November 2019

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas

scientific article

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

scientific article published on 07 February 2014

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

scientific article

Ultrastructural Studies in a Series of 18 Cases of Chromophobe Renal Cell Carcinoma

article published in 2005

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma

scientific article published on 25 February 2019

Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas

scientific article published on 26 November 2019

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy

scientific article published in June 2011

p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.

scientific article

List of works by Santiago Montes-Moreno

A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma

A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group

A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report with particular immunophenotypic features

Angioimmunoblastic T-cell lymphoma with a clonal plasma cell proliferation that underwent immunoglobulin isotype switch in the skin, coinciding with cutaneous disease progression

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

BCL7A protein expression in normal and malignant lymphoid tissues.

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

CD 30-positive transformed follicular lymphoma: two case reports and literature review.

CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options

CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Castleman Disease and Rosai-Dorfman Disease.

Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: A previously undescribed association of findings

Childhood florid follicular hyperplasia with immunoglobulin light-chain restriction in the gastrointestinal tract

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era

Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.

DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers

Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

E2F4 plays a key role in Burkitt lymphoma tumorigenesis

EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation

Early phase of Epstein-Barr virus (EBV)-positive diffuse large B cell lymphoma of the elderly mimicking EBV-positive reactive follicular hyperplasia

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options

Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases

Erdheim-Chester disease with isolated skeletal involvement in patient with odontalgia.

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

Expression pattern of XBP1(S) in human B-cell lymphomas

Follicular T-cell lymphoma: description of a case with characteristic findings suggesting it is a different condition from AITL

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.

Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment ⬇️

Identification of MNDA as a new marker for nodal marginal zone lymphoma.

Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues

In situ neoplasia in lymph node pathology.

Incidental and Isolated Follicular Lymphoma In Situ and Mantle Cell Lymphoma In Situ Lack Clinical Significance

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.

Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases.

Lack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.

Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.

Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.

Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.

MYD88L265P mutated IgA lymphoplasmacytic lymphoma

MicroRNA signatures in B-cell lymphomas.

MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas.

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.